N'-(4-hydroxybenzylidene)-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbohydrazide

ID: ALA4080993

Chembl Id: CHEMBL4080993

PubChem CID: 137648783

Max Phase: Preclinical

Molecular Formula: C17H16N2O4

Molecular Weight: 312.32

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(N/N=C/c1ccc(O)cc1)c1ccc2c(c1)OCCCO2

Standard InChI:  InChI=1S/C17H16N2O4/c20-14-5-2-12(3-6-14)11-18-19-17(21)13-4-7-15-16(10-13)23-9-1-8-22-15/h2-7,10-11,20H,1,8-9H2,(H,19,21)/b18-11+

Standard InChI Key:  ZJKPYAVOWVAJNF-WOJGMQOQSA-N

Alternative Forms

1. Parent:

   

   ALA4080993

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 312.32

Molecular Weight (Monoisotopic): 312.1110

AlogP: 2.32

#Rotatable Bonds: 3

Polar Surface Area: 80.15

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.09

CX Basic pKa: 1.40

CX LogP: 2.23

CX LogD: 2.22

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.67

Np Likeness Score: -1.15

References

1.  (2016)  7  (10): [10.1039/C6MD00263C]

Source

Source(1):

• Scientific Literature